Demant T, Gaw A, Watts G F, Durrington P, Buckley B, Imrie C W, Wilson C, Packard C J, Shepherd J
Institute of Biochemistry, Glasgow Royal Infirmary.
J Lipid Res. 1993 Jan;34(1):147-56.
The metabolism of apolipoprotein B-100 was studied in three patients with familial hyperchylomicronemia (type I hyperlipoproteinemia) using a very low density lipoprotein (VLDL) dual-tracer technique. Radioiodinated VLDL1 (Sf 60-400) and VLDL2 (Sf 20-60) were injected and their catabolism and rate of the transfer of apoB into VLDL2, intermediate density lipoprotein (IDL) (Sf 12-20), and low density lipoprotein (LDL) (Sf 0-12) were compared in patients and in five normolipidemic controls. The rates of delipidation of large triglyceride-rich VLDL1 to VLDL2 (0.26-0.54 pools/day vs. 2.5-5.2 pools/day in controls) and VLDL1 direct catabolism (0.33-0.92 pools/day vs. 4.2-14.7 pools/day in controls) were found to be significantly reduced in type I patients resulting in a tenfold increase of VLDL1 pool size. ApoB synthesis into this density interval was, however, normal as was that into smaller VLDL2. the circulating apoB mass in VLDL2 was not increased. In fact, apart from a modest decrease in the rate of VLDL2 delipidation to IDL and LDL, the behavior of apoB in this density interval was similar in hyperchylomicronemic and normal subjects. Likewise, the transfer of apoB through the IDL and LDL density ranges was not significantly different from normal. Pool sizes of these fractions, however, were reduced, the latter significantly (354-491 mg vs. 1,160-2,505 mg in controls) due to increased direct catabolism in hyperchylomicronemic patients. The results of this study indicate that lipoprotein lipase deficiency primarily affects VLDL1 metabolism, both its delipidation and direct removal from plasma. Lipolysis further down the delipidation cascade is not dependent on this enzyme. Hypercatabolism rather than a failure of synthesis of IDL and LDL was responsible for the decreased pools for both lipoproteins.
采用极低密度脂蛋白(VLDL)双示踪技术,对3例家族性高乳糜微粒血症(I型高脂蛋白血症)患者的载脂蛋白B-100代谢进行了研究。注射放射性碘标记的VLDL1(Sf 60 - 400)和VLDL2(Sf 20 - 60),并比较患者和5名血脂正常对照者中它们的分解代谢以及载脂蛋白B向VLDL2、中间密度脂蛋白(IDL)(Sf 12 - 20)和低密度脂蛋白(LDL)(Sf 0 - 12)的转移速率。发现I型患者中富含甘油三酯的大颗粒VLDL1向VLDL2的脱脂速率(0.26 - 0.54池/天,而对照组为2.5 - 5.2池/天)和VLDL1的直接分解代谢速率(0.33 - 0.92池/天,而对照组为4.2 - 14.7池/天)显著降低,导致VLDL1池大小增加了10倍。然而,该密度区间内载脂蛋白B的合成与较小的VLDL2中的合成一样正常。VLDL2中循环载脂蛋白B质量并未增加。实际上,除了VLDL2向IDL和LDL的脱脂速率略有降低外,在高乳糜微粒血症患者和正常受试者中,该密度区间内载脂蛋白B的行为相似。同样,载脂蛋白B通过IDL和LDL密度范围的转移与正常情况无显著差异。然而,这些组分的池大小减小,后者显著减小(354 - 491毫克,而对照组为1160 - 2505毫克),原因是高乳糜微粒血症患者中直接分解代谢增加。本研究结果表明,脂蛋白脂肪酶缺乏主要影响VLDL1代谢,包括其脱脂和从血浆中的直接清除。脱脂级联反应中更下游的脂解并不依赖于该酶。IDL和LDL池的减小是由于高分解代谢而非合成失败所致。